AN2 Therapeutics Inc. (ANTX)
undefined
undefined%
At close: undefined
1.38
-0.36%
After-hours Jan 06, 2025, 04:51 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -7.47 -4.46 -13.44 -21.22 -51.21
PS Ratio n/a n/a n/a n/a n/a
PB Ratio 3.88 1.94 -6.09 -14.2 59.96
P/FCF Ratio -9.07 -5.53 -14.09 -53.8 -116.09
P/OCF Ratio -9.07 -5.53 -14.09 -53.8 -116.09
OCF/S Ratio n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a 0.00 n/a n/a 0.15
Quick Ratio 7.87 13.72 17.70 2.90 35.85
Current Ratio 7.87 13.72 17.70 2.90 35.85
Asset Turnover n/a n/a n/a n/a n/a
Interest Coverage n/a -82.22 n/a n/a n/a
Return on Equity (ROE) -0.52 -0.43 0.45 0.67 -1.17
Return on Assets (ROA) -0.47 -0.4 -0.33 -3.21 -0.99
Return on Capital (ROIC) -0.56 -0.44 -0.35 -2.62 -0.93
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a